\
&
Contact us
\
&
Contact us
Published on | 8 months ago
Programmes Digital Europe HPC AI, data & cloud Cybersecurity Advanced Digital Skills Deployment: Best use of technologies Semiconductors European Digital Innovation HubsThe European Commission has published a Dashboard for the Digital Europe programme. The Dashboard displays data about the programme’s grants, providing an interface with numerous filter options allowing to personalise the rendering.
Pre-defined views have been created to further facilitate the user experience, the so-called profiles. The Dashboard currently features two profiles: the DIGITAL Country Profile and the DIGITAL Projects Profile, using interactive graphs, maps and tables with different functionalities. Dashboard’s components can be downloaded as pictures or structured data.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI, data & cloud Advanced Digital Skills Deployment: Best use of technologies
The first Digital Europe calls in the domains AI-continent, advanced digital skills and deployment & best use of digital technologies are now open for submission. Deadline to submit proposals for these calls is 2 September 2025. Please find here below an overview of all related call topics: AI-continent Apply AI: GenAI for the pu... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
